These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3106125)

  • 41. Induction of unresponsiveness to islet xenograft by MMC treatment of graft and blockage of LFA-1/ICAM-1 pathway.
    Grochowiecki T; Gotoh M; Dono K; Takeda Y; Sakon M; Yagita H; Okumura K; Miyasaka M; Monden M
    Transplantation; 2000 Apr; 69(8):1567-71. PubMed ID: 10836363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.
    Oura T; Ko DS; Boskovic S; O'Neil JJ; Chipashvili V; Koulmanda M; Hotta K; Kawai K; Nadazdin O; Smith RN; Cosimi AB; Kawai T
    Cell Transplant; 2016; 25(7):1331-41. PubMed ID: 26337731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
    J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolongation of rat islet allograft survival by the immunosuppressive agent leflunomide.
    Guo Z; Chong AS; Shen J; Foster P; Sankary HN; McChesney L; Mital D; Jensik SC; Williams JW
    Transplantation; 1997 Mar; 63(5):711-6. PubMed ID: 9075843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A technique for transplanting pancreatic islets as a vascularized graft and prevention of rejection with cyclosporin A.
    Reece-Smith H; Homan WP; Du Toit DF; McShane P; Morris PJ
    Transplantation; 1981 Jun; 31(6):442-4. PubMed ID: 6789508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
    Lord RH; Hancock WW; Colby AJ; Padberg W; Diamantstein T; Kupiec-Weglinski JW; Tilney NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):354-5. PubMed ID: 3079156
    [No Abstract]   [Full Text] [Related]  

  • 49. Synergy between subtherapeutic doses of cyclosporine and immunobiological manipulations in rat heart graft recipients.
    Tilney NL; Padberg WM; Lord RH; Araneda D; Strom TB; Kupiec-Weglinski JW
    Transplantation; 1988 Aug; 46(2 Suppl):122S-128S. PubMed ID: 2970137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
    Kupiec-Weglinski JW; Padberg W; Uhteg LC; Ma L; Lord RH; Araneda D; Strom TB; Diamantstein T; Tilney NL
    Eur J Immunol; 1987 Mar; 17(3):313-9. PubMed ID: 2952511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
    Wasowska B; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies.
    Auersvald LA; Rothstein DM; Oliveira SC; Khuong CQ; Onodera H; Lazarovits AI; Basadonna GP
    Transplantation; 1997 May; 63(9):1355-8. PubMed ID: 9158033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultraviolet light immunomodulation of canine islets for prolongation of allograft survival.
    Kenyon NS; Strasser S; Alejandro R
    Diabetes; 1990 Mar; 39(3):305-11. PubMed ID: 2106461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pretreatment of rat pancreatic islets with MHC I-A monoclonal antibody: in-vitro and in-vivo effects on islet antigenicity.
    Flesch BK; Bretzel RG; Otto DA; Ernst-Schlegel M; Federlin K
    Horm Metab Res; 1991 Aug; 23(8):357-61. PubMed ID: 1794836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of donor-specific unresponsiveness to rat cardiac allograft by donor leukocytes and cyclosporine.
    Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA
    Transplantation; 1988 Jun; 45(6):1131-5. PubMed ID: 3289153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
    Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ex vivo gene transfer of viral interleukin-10 to BB rat islets: no protection after transplantation to diabetic BB rats.
    Kuttler B; Wanka H; Klöting N; Gerstmayer B; Volk HD; Sawitzki B; Ritter T
    J Cell Mol Med; 2007; 11(4):868-80. PubMed ID: 17760846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy.
    Kupiec-Weglinski JW; Hahn HJ; Kirkman RL; Volk HD; Mouzaki A; DiStefano R; Tellides G; Dallman M; Morris PJ; Strom TB
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):207-16. PubMed ID: 3129841
    [No Abstract]   [Full Text] [Related]  

  • 60. Sex-associated differences in the survival of skin grafts in rats. Enhancement of cyclosporine immunosuppression in male compared with female recipients.
    Enosawa S; Hirasawa K
    Transplantation; 1989 Jun; 47(6):933-7. PubMed ID: 2660352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.